Close Menu

More articles about Clinical Proteomics

NEW YORK (GenomeWeb News) – Vermillion reported after the close of the market Wednesday that its fourth-quarter revenues increased 32 percent to $1.1 million from $868,000, beating the consensus Wall Street estimate for revenues of $900,000.

After years of technical setbacks and challenges, mass spec-based clinical proteomics is "ready for prime time," a Thermo Fisher Scientific researcher told ProteoMonitor this week.

NEW YORK (GenomeWeb News) – Irvine, Calif.-based Aviir announced yesterday that it has raised $10 million in a second tranche of a private financing round.

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it will collaborate with sera prognostics on the development of proteomic assays for early prediction of pregnancy complications.

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it has entered into a research collaboration with Ameritox to evaluate the use of Agilent's RapidFire platform in medication monitoring.

NEW YORK (GenomeWeb News) – Drug firm Summit and the Children's National Medical Center in Washington today announced a collaboration for the development of a proteomic assay to measure biomarkers in support of Summit's candidate drug for Duchenne Muscular Dystrophy (DMD).

NEW YORK (GenomeWeb News) – The National Cancer Institute said today that it has struck an agreement with a South Korean hospital to partner on the development and application of proteomic tools in a clinical environment.

A team of researchers at Boston Children's Hospital has identified a pair of urine biomarkers — filamin C and meprin A — that could be the first to provide accurate early diagnosis of Kawasaki disease.

Thermo Fisher Scientific last week announced a collaboration with German diagnostics firm Immundiagnostik for development of mass spec-based assays for protein and peptide quantitation.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and German diagnostics firm Immundiagnostik said today they are partnering to develop mass spectrometry-based assays for the qualitative and quantitative analysis of proteins and peptides.

NEW YORK (GenomeWeb News) – The Centre of Excellence for the Prevention of Organ Failure (PROOF) and MRM Proteomics announced today that they will partner on proteomic-based diagnostic tests for patients with chronic organ diseases.

NEW YORK (GenomeWeb News) – Foundation Medicine today said it and Novartis have reached a new agreement to use Foundation's clinical grade, next-generation sequencing to support the drug firm's clinical oncology programs.

Penn State Hershey Children's Hospital and Serametrix will collaborate on developing a serum-based assay that will measure autoantibodies to help doctors predict which patients are likely to respond to a brain cancer immunotherapy being developed by the hospital.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Applied Proteomics said today that it has reeled in $22.5 million in a Series B financing, has moved its corporate headquarters to San Diego, and has named Peter Klemm to be its CEO.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Biodesix today announced two partnerships to increase patient access to its VeriStrat molecular diagnostic test for non-small cell lung cancer.

Thermo Fisher Scientific said this week that it has acquired protein biomarker firm Intrinsic Bioprobes, adding to its clinical proteomics portfolio.

The partners will co-develop mass spectrometry-based tests to predict patient response to therapies such as tamoxifen.

Pages

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.